- - | |
---|---|
Price | |
- | |
Difference | - (-) |
ISIN | US00287Y1091 |
Symbol | ABBV |
Exchange | - |
Currency | - |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 312,951 EUR |
Benchmark | S&P 500 |
Bid (Bid size) | - |
Ask (Ask size) | - |
Open | - |
High | - |
Low | - |
Close (prev. day) | - |
VWAP | - |
Volume (pcs) | - |
Trading volume | - |
Number of trades | - |
Last size | - |
Related Futures | 15 |
Related Options | - |
Date | Headline | Download | |
2024/08/12 |
![]() |
Global Equity Ratings |
![]() |
2024/07/24 |
![]() |
Global Equity Ratings |
![]() |
2024/07/12 |
![]() |
Global Equity Ratings |
![]() |
2024/07/03 |
![]() |
Global Strategy 3Q 2024 |
![]() |
2024/06/21 |
![]() |
Global Equity Ratings |
![]() |
- - | |
---|---|
Price | |
- | |
Difference | - (-) |
ISIN | US00287Y1091 |
Symbol | ABBV |
Exchange | - |
Currency | - |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 312,951 EUR |
Benchmark | S&P 500 |
Bid (Bid size) | - |
Ask (Ask size) | - |
Open | - |
High | - |
Low | - |
Close (prev. day) | - |
VWAP | - |
Volume (pcs) | - |
Trading volume | - |
Number of trades | - |
Last size | - |
6m | 1Y | 3Y | |
Perf (%) | - | - | - |
Perf (abs.) | - | - | - |
Beta | 0.21 | 0.31 | 0.31 |
Volatility | - | - | - |
Ø price 5 days | Ø volume 5 days (pcs.) | - - (-) |
Ø price 30 days | Ø volume 30 days (pcs.) | - - (-) |
Ø price 100 days | Ø volume 100 days (pcs.) | - - (-) |
Ø price 250 days | Ø volume 250 days (pcs.) | - - (-) |
YTD High | date | - - (-) |
YTD Low | date | - - (-) |
52 Weeks High | date | - - (-) |
52 Weeks Low | date | - - (-) |
Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
Berlin | 2024/08/30 | 20:21 | 176.46 EUR | 0.00 | 18 |
Duesseldorf | 2024/08/30 | 19:30 | 175.96 EUR | 0.00 | 5 |
Euronext Milan MTF Global Equity Market | 2024/08/30 | 17:44 | 175.86 EUR | 0.00 | 1 |
Euronext Milan MTF Trading After Hours | 2024/07/26 | 19:50 | 171.10 EUR | 0.00 | 1 |
Frankfurt | 2024/08/30 | 11:00 | 177.92 EUR | 0.01 | 2 |
London Stock Exchange European Trade Reporting | 2024/08/30 | 17:30 | 195.185 USD | 0.00 | 3 |
Munich | 2024/08/30 | 17:19 | 176.04 EUR | 0.00 | 2 |
NYSE | 2024/08/30 | 22:00 | 196.31 USD | 747.95 | 52,753 |
Stuttgart | 2024/08/30 | 17:40 | 175.90 EUR | 0.03 | 7 |
Tradegate | 2024/08/30 | 22:26 | 177.58 EUR | 0.19 | 36 |
Vienna Stock Exchange | 2024/08/30 | 17:32 | 175.88 EUR | 0.00 | 5 |
Xetra | 2024/08/30 | 17:35 | 176.14 EUR | 0.08 | 23 |
ABBVIE INC. |
- - |
1 North Waukegan Road - 60064-6400 North Chicago |
Telefon: +1-847-932-7900 |
Fax: + |
E-mail: - |
AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |
Richard Gonzalez | Chairman of Board of Directors |
Robert Alpern | Member of Board of Directors |
Susan Quaggin | Member of Board of Directors |
Brett Hart | Member of Board of Directors |
Edward Rapp | Member of Board of Directors |
Frederick Waddell | Member of Board of Directors |
Glenn Tilton | Member of Board of Directors |
Jennifer Davis | Member of Board of Directors |
Melody Meyer | Member of Board of Directors |
Rebecca Roberts | Member of Board of Directors |
Roxanne Austin | Member of Board of Directors |
Thomas Freyman | Member of Board of Directors |
William Burnside | Member of Board of Directors |
Richard A. Gonzalez | Chairman of Managing Board |
Azita Saleki-Gerhardt | Member of Executive Committee |
Jeffrey R. Stewart | Member of Executive Committee |
Nicholas Donoghoe | Member of Executive Committee |
Perry C. Siatis | Member of Executive Committee |
Robert A. Michael | Member of Executive Committee |
Scott Reents | Member of Executive Committee |
Timothy J. Richmond | Member of Executive Committee |
Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.
By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer